astragaloside a has been researched along with oxidopamine in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | astragaloside a (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, WS; Durairajan, SS; Koo, I; Kum, WF; Li, M; Lu, JH; Wang, Y; Xie, LX; Yung, KK | 1 |
1 other study(ies) available for astragaloside a and oxidopamine
| Article | Year |
|---|---|
Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
Topics: Animals; Animals, Newborn; Cell Death; Cell Differentiation; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Nerve Degeneration; Neurites; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Saponins; Substantia Nigra; Sympatholytics; Triterpenes; Tyrosine 3-Monooxygenase | 2009 |